SEC Filing Details

Document Details

Form
Filing Date
Aug 7, 2019
Document Date
Aug 5, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
GOEDDEL DAVID V

Stock Quote

Contact Information

Investor Relations:
ir@ngmbio.com

Media Relations:
media@ngmbio.com

Top